2021 Q2 Form 10-Q Financial Statement

#000101447321000023 Filed on July 22, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $329.4M $314.4M $312.5M
YoY Change 4.78% 2.64% 2.0%
Cost Of Revenue $47.80M $43.61M $45.57M
YoY Change 9.61% -1.04% 0.15%
Gross Profit $281.6M $270.8M $267.0M
YoY Change 4.0% 3.25% 2.32%
Gross Profit Margin 85.49% 86.13% 85.42%
Selling, General & Admin $48.80M $45.78M $43.33M
YoY Change 6.61% 0.43% -2.68%
% of Gross Profit 17.33% 16.91% 16.23%
Research & Development $19.80M $18.20M $17.36M
YoY Change 8.78% 21.73% 7.6%
% of Gross Profit 7.03% 6.72% 6.5%
Depreciation & Amortization $11.98M $11.60M $11.20M
YoY Change 3.25% 2.65% -3.45%
% of Gross Profit 4.25% 4.28% 4.2%
Operating Expenses $68.60M $63.98M $60.69M
YoY Change 7.23% 5.69% 0.06%
Operating Profit $213.0M $206.8M $206.3M
YoY Change 3.01% 2.52% 3.0%
Interest Expense $23.10M $22.54M $22.54M
YoY Change 2.51% -0.44% -0.42%
% of Operating Profit 10.85% 10.9% 10.93%
Other Income/Expense, Net -$2.041M $7.403M $7.084M
YoY Change -127.57% -35.27% -41.95%
Pretax Income $187.9M $191.6M $190.8M
YoY Change -1.96% 0.61% 0.52%
Income Tax $40.20M $39.17M -$143.3M
% Of Pretax Income 21.39% 20.44% -75.1%
Net Earnings $147.7M $152.5M $334.1M
YoY Change -3.13% 3.35% 105.58%
Net Earnings / Revenue 44.84% 48.5% 106.91%
Basic Earnings Per Share
Diluted Earnings Per Share $1.313M $1.320M $2.863M
COMMON SHARES
Basic Shares Outstanding 112.4M shares 115.3M shares 116.4M shares
Diluted Shares Outstanding 112.5M shares 115.5M shares 116.7M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.123B $1.195B $1.139B
YoY Change -6.03% -2.45% -9.1%
Cash & Equivalents $216.5M $306.7M $498.7M
Short-Term Investments $906.5M $888.0M $640.0M
Other Short-Term Assets $66.08M $55.08M $46.86M
YoY Change 19.98% -21.81% -24.75%
Inventory
Prepaid Expenses $30.69M $24.50M $16.61M
Receivables $4.956M $5.338M $5.047M
Other Receivables $4.829M $0.00 $0.00
Total Short-Term Assets $1.189B $1.250B $1.185B
YoY Change -4.85% -3.53% -9.87%
LONG-TERM ASSETS
Property, Plant & Equipment $247.7M $250.3M $247.8M
YoY Change -1.04% -0.21% -1.77%
Goodwill $52.53M $52.53M $52.53M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $40.65M $40.61M $38.69M
YoY Change 0.09% 12.03% 12.29%
Total Long-Term Assets $552.3M $570.5M $568.4M
YoY Change -3.18% -4.04% -5.96%
TOTAL ASSETS
Total Short-Term Assets $1.189B $1.250B $1.185B
Total Long-Term Assets $552.3M $570.5M $568.4M
Total Assets $1.741B $1.820B $1.754B
YoY Change -4.33% -3.69% -8.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.74M $15.00M $10.00M
YoY Change -21.74% 25.0% -28.57%
Accrued Expenses $87.01M $81.00M $88.00M
YoY Change 7.42% -15.63% -5.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $998.3M $1.018B $955.7M
YoY Change -1.96% 8.95% 1.53%
LONG-TERM LIABILITIES
Long-Term Debt $1.785B $1.789B $1.788B
YoY Change -0.24% 0.17% 0.11%
Other Long-Term Liabilities $86.30M $131.6M $138.1M
YoY Change -34.45% -57.25% -55.33%
Total Long-Term Liabilities $2.161B $2.202B $2.207B
YoY Change -1.87% -7.49% -7.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $998.3M $1.018B $955.7M
Total Long-Term Liabilities $2.161B $2.202B $2.207B
Total Liabilities $3.159B $3.220B $3.163B
YoY Change -1.9% -2.85% -4.9%
SHAREHOLDERS EQUITY
Retained Earnings -$15.36B -$15.99B -$16.14B
YoY Change -3.92% -4.7% -4.63%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $11.34B $10.63B $10.48B
YoY Change 6.68% 8.47% 8.94%
Treasury Stock Shares 242.1M shares 238.6M shares 237.9M shares
Shareholders Equity -$1.418B -$1.400B -$1.409B
YoY Change
Total Liabilities & Shareholders Equity $1.741B $1.820B $1.754B
YoY Change -4.33% -3.69% -8.64%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $147.7M $152.5M $334.1M
YoY Change -3.13% 3.35% 105.58%
Depreciation, Depletion And Amortization $11.98M $11.60M $11.20M
YoY Change 3.25% 2.65% -3.45%
Cash From Operating Activities $142.5M $215.3M $180.1M
YoY Change -33.79% 30.56% -3.88%
INVESTING ACTIVITIES
Capital Expenditures -$17.57M -$10.90M $11.01M
YoY Change 61.19% -1.8% 20.58%
Acquisitions
YoY Change
Other Investing Activities $27.89M -$242.6M $90.10M
YoY Change -111.49% 16073.33% 2945.98%
Cash From Investing Activities $10.32M -$253.5M $79.08M
YoY Change -104.07% 1911.9% -81.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $275.6M
YoY Change 34.91%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -183.5M -154.2M -$267.3M
YoY Change 18.98% -14.48% 36.36%
NET CHANGE
Cash From Operating Activities 142.5M 215.3M $180.1M
Cash From Investing Activities 10.32M -253.5M $79.08M
Cash From Financing Activities -183.5M -154.2M -$267.3M
Net Change In Cash -30.61M -192.4M -$9.499M
YoY Change -84.09% 587.14% -102.25%
FREE CASH FLOW
Cash From Operating Activities $142.5M $215.3M $180.1M
Capital Expenditures -$17.57M -$10.90M $11.01M
Free Cash Flow $160.1M $226.2M $169.0M
YoY Change -29.22% 28.52% -5.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
VERISIGN INC/CA
dei Entity Central Index Key
EntityCentralIndexKey
0001014473
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-23593
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3221585
dei Entity Address Address Line1
EntityAddressAddressLine1
12061 Bluemont Way,
dei Entity Address City Or Town
EntityAddressCityOrTown
Reston,
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20190
dei City Area Code
CityAreaCode
703
dei Local Phone Number
LocalPhoneNumber
948-3200
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
VRSN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
111874436 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
216497000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
401194000 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
906492000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
765713000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
66078000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
51033000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1189067000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1217940000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
247694000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
245571000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
52527000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
52527000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
66441000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
67914000 USD
CY2021Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40651000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37958000 USD
CY2021Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
552313000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
548970000 USD
CY2021Q2 us-gaap Assets
Assets
1741380000 USD
CY2020Q4 us-gaap Assets
Assets
1766910000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
175350000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208642000 USD
CY2021Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
822984000 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
780051000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
998334000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
988693000 USD
CY2021Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
289881000 USD
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
282838000 USD
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1790083000 USD
CY2021Q2 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1784654000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
86296000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
95494000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2160831000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2168415000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
3159165000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
3157108000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
354071000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
353789000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112001000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113470000 shares
CY2021Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
13949525000 USD
CY2020Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
14275160000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15364476000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15662602000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2834000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2756000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1417785000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1390198000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1741380000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1766910000 USD
CY2021Q2 us-gaap Revenues
Revenues
329405000 USD
CY2020Q2 us-gaap Revenues
Revenues
314365000 USD
us-gaap Revenues
Revenues
653026000 USD
us-gaap Revenues
Revenues
626889000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
47796000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
43608000 USD
us-gaap Cost Of Revenue
CostOfRevenue
94764000 USD
us-gaap Cost Of Revenue
CostOfRevenue
89181000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10221000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8890000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18705000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15494000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19808000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18202000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40119000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35560000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38601000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36885000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
76052000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
73610000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
116426000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112905000 shares
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
107585000 USD
us-gaap Costs And Expenses
CostsAndExpenses
229640000 USD
us-gaap Costs And Expenses
CostsAndExpenses
213845000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
212979000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
206780000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
423386000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
413044000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
23064000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
22535000 USD
us-gaap Interest Expense
InterestExpense
45598000 USD
us-gaap Interest Expense
InterestExpense
45070000 USD
CY2021Q2 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-2041000 USD
CY2020Q2 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
7403000 USD
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-1597000 USD
us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
14487000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
187874000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
191648000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
376191000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
382461000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40102000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39169000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78065000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-104134000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
147772000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
152479000 USD
us-gaap Net Income Loss
NetIncomeLoss
298126000 USD
us-gaap Net Income Loss
NetIncomeLoss
486595000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-87000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-78000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
263000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
147685000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
150479000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
298048000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
486858000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.31
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.32
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.64
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.20
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.31
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.32
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.64
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.19
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112387000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115347000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112757000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115861000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112517000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115544000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116137000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1403760000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-1409114000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1390198000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1490100000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1417785000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1400324000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1417785000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1400324000 USD
us-gaap Profit Loss
ProfitLoss
298126000 USD
us-gaap Profit Loss
ProfitLoss
486595000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
23577000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
22841000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
26591000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
23428000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4398000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
8101000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18602000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10146000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-36787000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25796000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
49976000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
30430000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
6435000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
175471000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
340844000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
395372000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1482952000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
995194000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1623566000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1167680000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24270000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21891000 USD
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
0 USD
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
-20009000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-164884000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-174368000 USD
us-gaap Repayments Of Debt Maturing In More Than Three Months
RepaymentsOfDebtMaturingInMoreThanThreeMonths
750000000 USD
us-gaap Repayments Of Debt Maturing In More Than Three Months
RepaymentsOfDebtMaturingInMoreThanThreeMonths
0 USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
742329000 USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
361199000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
429826000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8101000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8296000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-360769000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-421530000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-364000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-965000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-185173000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-201491000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
410601000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
517601000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
225428000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316110000 USD
us-gaap Interest Paid Net
InterestPaidNet
48718000 USD
us-gaap Interest Paid Net
InterestPaidNet
43708000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
98993000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26472000 USD
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28078000 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
28832000 USD
CY2021Q2 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
3698000 USD
CY2020Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
4176000 USD
CY2021Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
193652000 USD
CY2020Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
129627000 USD
CY2021Q2 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
906492000 USD
CY2020Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
1013679000 USD
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1131920000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1176314000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
216497000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
401194000 USD
CY2021Q2 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
8931000 USD
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
9407000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
225428000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
410601000 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
906492000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
765713000 USD
CY2021Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1131920000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1176314000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
100000 USD
CY2021Q2 vrsn Debtinstrumentfairvalueseniornotes2025
Debtinstrumentfairvalueseniornotes2025
568200000 USD
CY2021Q2 vrsn Debt Instrument Fair Value Senior Notes2027
DebtInstrumentFairValueSeniorNotes2027
586500000 USD
CY2021Q2 vrsn Debt Instrument Fair Value Senior Notes2031
DebtInstrumentFairValueSeniorNotes2031
761600000 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30690000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17920000 USD
CY2021Q2 vrsn Prepaidregistryfeescurrent
Prepaidregistryfeescurrent
23974000 USD
CY2020Q4 vrsn Prepaidregistryfeescurrent
Prepaidregistryfeescurrent
22654000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4956000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4642000 USD
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4829000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3572000 USD
CY2021Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1629000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
40651000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2245000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
66078000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
51033000 USD
CY2021Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
11089000 USD
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
7105000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10318000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11277000 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
8931000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
9407000 USD
CY2021Q2 vrsn Prepaidregistryfeesnoncurent
Prepaidregistryfeesnoncurent
8232000 USD
CY2020Q4 vrsn Prepaidregistryfeesnoncurent
Prepaidregistryfeesnoncurent
7997000 USD
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2081000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2172000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
242100000 shares
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37958000 USD
CY2021Q2 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
9500000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
18800000 USD
CY2021Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
11739000 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
12340000 USD
CY2021Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
52659000 USD
CY2020Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
53631000 USD
CY2021Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
43080000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
54596000 USD
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
19895000 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
24408000 USD
CY2021Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
14502000 USD
CY2020Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
27194000 USD
CY2021Q2 vrsn Accruedfees
Accruedfees
14216000 USD
CY2020Q4 vrsn Accruedfees
Accruedfees
13090000 USD
CY2021Q2 vrsn Customer Incentives Payable
CustomerIncentivesPayable
9437000 USD
CY2020Q4 vrsn Customer Incentives Payable
CustomerIncentivesPayable
12556000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9822000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10827000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
175350000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208642000 USD
CY2021Q2 vrsn Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
82427000 USD
CY2020Q4 vrsn Other Tax Liabilities Noncurrent
OtherTaxLiabilitiesNoncurrent
90335000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3869000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5159000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
86296000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
95494000 USD
CY2021Q2 us-gaap Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability Current
TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent
7700000 USD
vrsn Additionalsharerepurchaseamountauthorized
Additionalsharerepurchaseamountauthorized
747000000.0 USD
CY2020Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
253000000.0 USD
CY2021Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
737500000 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
11340000000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112387000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115347000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112757000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115861000 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
130000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
197000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
148000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
276000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112517000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115544000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112905000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116137000 shares
CY2021Q2 us-gaap Revenues
Revenues
329405000 USD
CY2020Q2 us-gaap Revenues
Revenues
314365000 USD
us-gaap Revenues
Revenues
653026000 USD
us-gaap Revenues
Revenues
626889000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
510500000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
13617000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
11987000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
26591000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
23428000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
458000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
527000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
872000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1020000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
13617000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
11987000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
26591000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
23428000 USD
CY2020Q2 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
2274000 USD
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
327000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2149000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2149000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q2 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
111000 USD
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
6695000 USD
CY2021Q2 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2020Q2 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
5153000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
5611000 USD
CY2021Q2 vrsn Incomefromtransitionservices
Incomefromtransitionservices
0 USD
CY2020Q2 vrsn Incomefromtransitionservices
Incomefromtransitionservices
0 USD
vrsn Incomefromtransitionservices
Incomefromtransitionservices
0 USD
vrsn Incomefromtransitionservices
Incomefromtransitionservices
2100000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
225000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2041000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7403000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1597000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14487000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40102000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39169000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78065000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-104134000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 Rate
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.20 Rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 Rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.27 Rate
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 Rate
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
167800000 USD

Files In Submission

Name View Source Status
0001014473-21-000023-index-headers.html Edgar Link pending
0001014473-21-000023-index.html Edgar Link pending
0001014473-21-000023.txt Edgar Link pending
0001014473-21-000023-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrsn-20210630.htm Edgar Link pending
vrsn-20210630.xsd Edgar Link pending
vrsn-20210630_cal.xml Edgar Link unprocessable
vrsn-20210630_def.xml Edgar Link unprocessable
vrsn-20210630_htm.xml Edgar Link completed
vrsn-20210630_lab.xml Edgar Link unprocessable
vrsn-20210630_pre.xml Edgar Link unprocessable
vrsn-2021630x10qxex3101.htm Edgar Link pending
vrsn-2021630x10qxex3102.htm Edgar Link pending
vrsn-2021630x10qxex3201.htm Edgar Link pending
vrsn-2021630x10qxex3202.htm Edgar Link pending